New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and ...

The FDA approved the LimFlow system designed to stave off amputation for people with chronic limb-threatening ischemia (CLTI) and no treatment alternatives, device maker LimFlow SA announced Tuesday.

BEAUFORT, S.C.--(BUSINESS WIRE)--Recent research published by THE SAGE GROUP examined the number of PAD patients undergoing endovascular procedures by site of service; hospital inpatient, hospital ...

Please provide your email address to receive an email when new articles are posted on . IVUS-guided angioplasty for peripheral artery disease improved procedural outcomes vs. an angiography-guided ...

The new joint guideline from the American Heart Association and the American College of Cardiology provides recommendations to guide clinicians in the treatment of patients with lower extremity ...

Compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with lower risks of cardiac death and composite renal outcomes without ...

Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care from a multispecialty team, are essential to help prevent amputation and other cardiovascular ...

When most people think of atherosclerosis, coronary artery disease (CAD) and stroke come to mind, but a strong third player on the atherosclerotic landscape is peripheral artery disease (PAD). This ...

If you have not heard of peripheral artery disease, or PAD, you are not alone. While clinicians and health organizations have made headway in raising awareness that heart disease is the No. 1 cause of ...

Please provide your email address to receive an email when new articles are posted on . Ozempic improved walking distance in patients with diabetes and peripheral artery disease at 1 year. An ...